Geographic · Revenue

EMEA — Revenue

ALMR EMEA — Revenue increased by 179.3% to $3.97M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful expansion and growing demand for the company's proteomics solutions within the EMEA market, while a decrease may signal competitive pressure or challenges in regional distribution and adoption.

Detailed definition

This metric represents the total revenue generated from contracts with customers located within the Europe, Middle East,...

Peer comparison

Peers in the life sciences and diagnostics sector typically report regional revenue to demonstrate global commercial scaling, with growth rates often benchmarked against regional healthcare R&D spending trends.

Metric ID: almr_segment_emea_revenue_from_contract_with_customer_excluding_assessed_tax

Historical Data

2 periods
 Q1 '25Q1 '26
Value$1.42M$3.97M
QoQ Change+179.3%
YoY Change+179.3%
Range$1.42M$3.97M
Avg YoY Growth+179.3%
Median YoY Growth+179.3%

Frequently Asked Questions

What is ALMR's emea — revenue?
ALMR (ALMR) reported emea — revenue of $3.97M in Q1 2026.
What does emea — revenue mean?
The total sales revenue earned from customers located in the EMEA region, excluding taxes.